Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209) - Concepedia

Concepedia

Publication | Open Access

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

DOI Full Paper Access

313

Citations

19

References

2020

Year

David S. Miller, Virginia L. Filiaci, Robert S. Mannel, David E. Cohn, Takashi Matsumoto, Krishnansu S. Tewari, Paul DiSilvestro, Michael L. Pearl, Peter A. Argenta, Matthew A. Powell,

Journal of Clinical Oncology

Abstract

With demonstrated noninferiority to TAP, TC is the global first-line standard for advanced endometrial cancer.

References

	Year	Citations

Page 1